News Release

Latest News

Press Release: Oktober 1, 2023

SIS Medical AG Expands Presence with Direct Operations in Germany

Transitioning from Distribution to Direct Sales to Drive Enhanced Customer and Market Engagement

Frauenfeld, October 5th — SIS-Medical, a leading provider in the medical device industry specializing in high quality dedicated PTCA balloon catheters, is delighted to announce the commencement of its direct operations in Germany, an evolution from its longstanding distribution partnership with Nicolai Medizintechnik GmbH.

A Focused Shift to Direct Sales

After more than 10 years of a successful and collaborative partnership with Nicolai Medizintechnik GmbH, SIS-Medical through its German entity and subsidiary will now steer its PTCA business in Germany with a direct sales model. This strategic move aims to amplify customer engagement, enhance market response, and further penetrate one of the most vital medical device markets in Europe.

Strengthening Connections with a Dedicated Team

To ensure a smooth transition and continuous, high-level service to our customers, SIS-Medical has established a robust team of seasoned professionals to drive our PTCA business in the region. The team, with their profound expertise and knowledge, will navigate through the intricacies of the market, affirming SIS-Medical’s commitment to delivering unparalleled solutions and services to our esteemed partners and customers in the field of complex and challenging Percutaneous Coronary Interventions (PCIs.)

A Grateful Acknowledgement

We extend our deepest gratitude to Nicolai Medizintechnik GmbH for their unwavering support, dedication, and significant contributions towards shaping SIS-Medical’s journey in the German market over the years. As we embark on this new chapter, we anticipate that our enhanced operational structure will bring forth elevated experiences and innovative solutions to our customers.

About SIS-Medical

Founded in 2007 Winterthur, Switzerland. SIS Medical has always been and will still be dedicated to develop, produce and distribute innovative high performance PTCA Balloon Catheters which are designed to facilitate the daily work of the user, help to extent treatment options and to improve the quality of patients live.
Our target is to provide best in class devices for an optimal lesion preparation prior to stent (DES) implantation in order to optimize long term clinical outcome.

Press Release: February 2, 2023

SIS Medical AG (Swiss Interventional Systems), a globally leading developer, manufacturer and distributor of high-quality and high-performance products in the field of interventional cardiology, announces the launch of its lead product OPN NC® PTCA Dilatation Catheter with TWIN-Wall technology in the US. The product extends treatment options by high performance and safety as well as providing success rates where other balloons fail. It is distributed by Worldwide Innovations & Technologies, Inc. (manufacturer and distributor of RADPAD® Radiation Protection Products), which is headquartered in Lenexa, Kansas.

“I was extremely satisfied with the performance of the OPN NC® balloon. We were successful in efficiently treating multiple patients with very complex and calcified lesions. The OPN NC® balloon is an essential tool for operators treating resistant lesions, restenosis, or to treat acutely under-expanded stent, and is a true cost-effective technology compared to other devices.”
Dr. Philippe Genereux, Morristown Medical Center in New Jersey.

Read more at the Medical Device News Magazine

 

Press Release - Frauenfeld, Switzerland - March 23rd, 2022

SIS Medical AG (Swiss Interventional Systems), a globally leading developer, manufacturer and distributor of high-quality and high-performance products in the field of interventional cardiology, announces the approval by the U.S. Food & Drug Administration of its lead product OPN NC Super High Pressure PTCA Balloon Catheter under 510(k) number K212393.

SIS Medical AG receives FDA 510(k) approval for its lead product, OPN NC® TWIN-Wall Super High Pressure PTCA Balloon

 

Just on-line published, 03 December 2020, at the EuroIntervention Journal!

Super High - Pressure Balloon versus Scoring Balloon to Prepare Severely Calcified Lesions : The ISAR – CALC Randomised Trial

For more details, please go to:

Super High-Pressure Balloon versus Scoring Balloon to Prepare Severely Calcified Coronary Lesions: The ISAR-CALC Randomized Trial - EuroIntervention (pcronline.com)

 

Sergej Kammerzell to be appointed new CEO of SIS Medical AG, April 2020: New CEO of SIS Medical AG

 

Congress Participation

 

May 16-19th 2023

EuroPCR
Palais des congrès, Paris

EuroPCR